[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336941-105":59,"doc-detail-336941-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gprasp-protein-deficiency-triggers-lymphoproliferative-disease-by-affecting-b-cell-differentiation","GPRASP protein deficiency triggers lymphoproliferative disease by affecting B-cell differentiation","","Gprasp1 and Gprasp2 encode proteins that govern CXCR4 stability and cellular trafficking, shaping proper B-cell transport within germinal centers. Deficient B-cells accumulate in the germinal center, display transcriptional abnormalities that disrupt Aicda regulation, and become exposed to excessive somatic hypermutation. In mouse transplant models, about 30% of recipients develop aggressive, fatal B-cell hyperproliferative disease by 20–50 weeks. Histology and molecular profiling show neoplasms resembling human germinal-center origin high-grade B-cell lymphomas with elevated mutational burden and heterogeneous signatures, indicating reduced Gprasp1/2 expression impairs B-cell maturation and increases neoplasm risk.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gprasp-protein-deficiency-triggers-lymphoproliferative-disease-by-affecting-b-cell-differentiation/336941/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gprasp-protein-deficiency-triggers-lymphoproliferative-disease-by-affecting-b-cell-differentiation/336941.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What do Gprasp1 and Gprasp2 control in B-cells?","Question",{"text":112,"@type":113},"Gprasp1 and Gprasp2 regulate the stability and cellular trafficking of CXCR4, which is required for appropriate B-cell trafficking in germinal centers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does Gprasp deficiency affect Aicda expression and somatic hypermutation?",{"text":117,"@type":113},"Gprasp1- and Gprasp2-deficient B-cells show transcriptional abnormalities affecting mechanisms that control Aicda expression, leading to excessive somatic hypermutation.",{"name":119,"@type":110,"acceptedAnswer":120},"What disease outcomes are observed in the mouse transplant model?",{"text":121,"@type":113},"About 30% of mice receiving Gprasp-deficient hematopoietic stem and progenitor cells develop a biologically aggressive and fatal B-cell hyperproliferative disease within 20–50 weeks posttransplant.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336941,1790637945,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOI: 10.1002/hem3.70037  \nARTICLE  \nGPRASP protein deficiency triggers lymphoproliferative disease by affecting B‐cell differentiation  \nAntonio Morales‐Hernández1  | Emilia Kooienga2 | Heather Sheppard3 |  \nGabriela Gheorghe3 | Claire Caprio2 | Ashley Chabot2 | Shannon McKinney‐Freeman2  \nGraphical Abstract  \nDOI: 10.1002/hem3.70037  \nARTICLE  \nGPRASP protein deficiency triggers lymphoproliferative disease by affecting B‐cell differentiation  \nAntonio Morales‐Hernández1  | Emilia Kooienga2 | Heather Sheppard3 |  \nGabriela Gheorghe3 | Claire Caprio2 | Ashley Chabot2 | Shannon McKinney‐Freeman2  \nCorrespondence: Antonio Morales‐Hernández ([antmor@umich.edu](antmor@umich.edu)); Shannon McKinney‐Freeman ([shannon.mckinney-freeman@stjude.org](shannon.mckinney-freeman@stjude.org))  \nAbstract  \nGprasp1 and Gprasp2 encode proteins that control the stability and cellular trafficking of CXCR4, a master regulator of hematopoiesis whose dynamic regulation is required for appropriate trafficking of B‐cells in the germinal center (GC) . Here, we report that Gprasp1 and Gprasp2‐deficient B‐cells accumulate in the GC and show transcriptional abnormalities, affecting the mechanisms controlling Aicda expression and exposing them to excessive somatic hypermutation. Consequently, about 30% of mice transplanted with Gprasp‐deficient hematopoietic stem and progenitor cells developed a biologically aggressive and fatal B‐cell hyperproliferative disease by 20–50 weeks posttransplant. Histological and molecular profiling reveal that Gprasp1‐ and Gprasp2‐deficient neoplasms morphologically resemble human high‐grade B‐cell lymphomas of germinal center origin with shared morphologic features of both Burkitt Lymphoma (BL) and diffuse large B‐cell lymphoma (DLBCL), and molecular features consistent with DLBCL, as well as elevated mutational burden and heterogenous transcriptional and mutational signature. Thus, reduced Gprasp1 and Gprasp2 gene expression perturbs B‐cell maturation and increases the risk of B‐cell neoplasms of germinal center origin. As this model recapitulates the essential features of the heterogenous group of human hematopoietic malignancies, it could be a powerful tool to interrogate the mechanisms of lymphomagenesis for these cancers.  \nINTRODUCTION  \nThe mechanisms that drive normal B‐cell differentiation and activation are frequently subverted in B‐cell lymphomas, which promotes uncontrolled growth and survival.1 Germinal center (GC) B‐cells are ata particularly high risk for malignant transformation due to attenuation of specific DNA damage and cell proliferation checkpoints essential for immunoglobulin affinity maturation.2 Although the GC stage is tightly regulated, somatic hypermutation (SHM) can disrupt this equilibrium by generating off‐target mutations that could potentially impose a selective advantage on maturing B‐cells.2,3 Indeed, some healthy individuals harbor premalignant populations of mutant B‐cells,4,5 although it is currently not possible to discern who is at risk for transformation to overt disease.2 Revelations in the regulation of GC epigenetics, metabolism, signaling, and immune synapses have revealed that these regulatory processes can be hijacked to facilitate lymphomagenesis.2 In the GC, B‐cells acquire the molecular profiles that determine their fate—proliferation, apoptosis, export—depending  \n1Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, Michigan, USA  \n2Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA  \non the affinity of their surface receptors for antigen.6 CXCR4 has a crucial role in the regulation of the dynamic transitions between the light zone and the dark zone of the GC, which is critical for B‐cell differentiation.7 Indeed, dysregulation of CXCR4, among other lesions identified, contributes to the progression and survival of neoplastic B‐ cells, conferring prognostic value to CXCR4 .2,3,8,9 Mature B‐","cbCaitGmR4po7UGu","https://ap.wps.com/l/cbCaitGmR4po7UGu","pdf",4715754,15,"English","# Abstract\n# Introduction\n## Germinal center biology and transformation risk\n## CXCR4 regulation in B-cell fate transitions\n## Knowledge gap for GPRASP function and study rationale\n## Model and key findings summary","[{\"question\":\"What do Gprasp1 and Gprasp2 control in B-cells?\",\"answer\":\"Gprasp1 and Gprasp2 regulate the stability and cellular trafficking of CXCR4, which is required for appropriate B-cell trafficking in germinal centers.\"},{\"question\":\"How does Gprasp deficiency affect Aicda expression and somatic hypermutation?\",\"answer\":\"Gprasp1- and Gprasp2-deficient B-cells show transcriptional abnormalities affecting mechanisms that control Aicda expression, leading to excessive somatic hypermutation.\"},{\"question\":\"What disease outcomes are observed in the mouse transplant model?\",\"answer\":\"About 30% of mice receiving Gprasp-deficient hematopoietic stem and progenitor cells develop a biologically aggressive and fatal B-cell hyperproliferative disease within 20–50 weeks posttransplant.\"}]","GPRASP protein deficiency triggers lymphoproliferative disease by affecting B-cell differentiation | PDF",1790017154,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e90504220d14fdbd9ef90d241de057ee.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75985fcc4fd89246b4ad416a72364a1d.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a710cf260f2488ae0690e4d91a3f0d0.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbd2c6d33dfdb93a1c1add4f7c4566eb.webp",980,1287]